weight loss

weight loss drugs obesity
Biotech

Roche's obesity ambition not reliant on one megablockbuster

Roche’s head of metabolic development said the company is firing “on full cylinders” to get a phase 3 trial of its GLP-1/GIP drug launched next year.
James Waldron Sep 23, 2025 7:45am
Roche Teresa Graham Pharma Day

Roche unveils strategy to become 'top 3' obesity company

Sep 22, 2025 8:05am
obesity overweight weight loss weigh

Novo pushes ahead with amylin after seeing ph. 3 tolerability

Sep 16, 2025 8:12am
Dexcom Stelo sensor on upper arm

FDA clears Signos' over-the-counter, CGM-powered weight loss app

Aug 20, 2025 10:44am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am
Image of brain with hindbrain highlighted

Mice given a brain protein lost weight without getting nauseous

Jul 24, 2025 7:00am